SENSEX 77414.92 ▼ (0.25%)
BSE BANKEX 59542.38 ▲ (0.36%)

OXYGENTA PHARMACEUTICAL LIMITE

BSE: 524636 29 Sep 2025
Healthcare
₹ 70
OXYGENTA PHARMACEUTICAL LIMITED specializes in Pharmaceuticals within the Healthcare sector.

OXYGENTA PHARMACEUTICAL LIMITE - Share Price & Details

Market Cap
₹456.0
High /Low
134.0 / 30.0
Stock P/E
NA
Book Value
₹-6.93
Dividend Yield
0.0
ROCE
-33.4
ROE
₹NA
Face Value
10.0
PEG Ratio
NA
EVEBITDA
₹-59.7
Debt
62.2
CMP / FCF
-36.9
Debt to equity
₹NA
NP Ann
-10.3
High price all time
134.0
Piotroski score
₹5.0
Graham Number
NA
No. Eq. Shares
3.7
Net CF
₹0.02
Net profit
-10.3
Price to book value
NA
Interest Coverage
₹-6.91
Low price all time
2.95
Industry PE
33.8
Reserves
₹-62.6
Free Cash Flow
₹-8.67

Broker Recommendations

No broker recommendations available

We couldn’t find any recent recommendations for this company (matched by symbol or BSE code). Please check back later.


Price Chart


Volume Chart


Peer Comparison

Stock Total Income Net Profit Net Sales EPS Market Cap (in Cr) P/E
FABINO ENTERPRISES LIMITEDNANANANA5.0984.8
Triochem Products Ltd.,NANANANA0
OXYGENTA PHARMACEUTICAL LIMITENANANANA456.0
ALBERT DAVID LTD.926.0379.38705.6613.9144370.5
BAFNA PHARMACEUTICALS LTD.352.233.89346.241.4341741.4

Peer Comparison Chart


About OXYGENTA PHARMACEUTICAL LIMITE

OXYGENTA PHARMACEUTICAL LIMITED, with Security Code 524636, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.


Order Book


Latest News

Will Market Volatility Create Buying Opportunities for Indo Us Bio - High Yield Income Stocks & Start Building Capital with Zero Risk

(28 Sep 2025)
【Market Insights】✌️ Access real-time market intelligence and exclusive stock alerts proven to deliver over 200% gains for smart investors.
Read more →

Oxygenta Pharmaceutical Shows Mixed Performance Amid Strong Long-Term Growth Trends

(24 Sep 2025)
Oxygenta Pharmaceutical, a microcap in the Pharmaceuticals & Biotechnology sector, has shown varied trading performance.
Read more →

Oxygenta Pharmaceutical Faces Technical Shift Amidst Mixed Financial Indicators and Stakeholder Confidence

(02 Sep 2025)
Oxygenta Pharmaceutical has experienced a recent evaluation adjustment, reflecting shifts in its technical indicators. While the stock shows a notable...
Read more →

Oxygenta Pharmaceutical schedules AGM

(29 Aug 2025)
Oxygenta Pharmaceutical announced that the 32th Annual General Meeting(AGM) of the company will be held on 19 September 2025.
Read more →

How does Tri Continental Corporation Preferred Security generate profit in a changing economy - Gain access to exclusive stock analysis

(28 Aug 2025)
【Market Sentiment】✌️ Our platform specializes in identifying explosive growth stocks with a proven record of exceeding 200% ROI for savvy...
Read more →

How does MAYAR generate profit in a changing economy - Capitalize on momentum-driven investment opportunities

(18 Aug 2025)
【Market Discussions】✌️ From trend reversals to momentum rallies, we track the moves that matter — often delivering 2x–4x gains to our...
Read more →